Kidney community steps up to support Kidney Beam

16 December 2021
Kidney Beam, the platform helping kidney patients’ wellbeing through live, online and on-demand exercise classes and programmes, is being bolstered by support across the kidney community.In an unprecedented move, the UK Kidney Association is joining forces with Kidney Research UK, Kidney Care UK and...
Read more

COVID-19 update for professionals

14 December 2021
Thank you to everybody for the work that you are doing, these are incredibly tough times and the last 20 months have been unparalleled in our careers as health care professionals. What is coming in the next few months may be even more challenging, therefore the UKKA and renal community COVID-19...
Read more

Latest information on COVID-19 for patients

14 December 2021
There continues to be uncertainty around the new Omicron COVID-19 variant, but the spread of the variant is increasing rapidly throughout the UK and will soon become the dominant variant.There is increasing evidence that people with kidney disease who have had two vaccines are at substantially...
Read more

Terry Feest Award 2020

5 November 2021
Here at the UK Renal Registry (UKRR), we recognise that a lot of people have contributed to the work that we do, freely giving their own time and with very little direct recognition.In 2013, a new award was created, the ‘Terry Feest’ award, in recognition of the contribution made by Terry, not only...
Read more

Applications invited - Francis Crick Institute PhD for Clinicians

25 October 2021
Applications are now invited for the Francis Crick Institute PhD for Clinicians.The fellowships provide an opportunity for talented clinicians passionate about research, with a strong academic track record, to perform biomedical discovery research while following our three-year clinical PhD...
Read more

SGLT-2 Inhibition in Adults with Kidney Disease

18 October 2021
The UK Kidney Association Clinical Practice Guideline Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease has now been published. "SGLT-2 inhibitors represent the most significant advance in the management of progressive CKD identified over the last 20 years and the...
Read more